Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern

  • End date
    Apr 13, 2023
  • participants needed
  • sponsor
    Sociedad Española de Neumología y Cirugía Torácica
Updated on 13 May 2022
continuous positive airway pressure
hypopnoea syndrome


The principal objective is to evaluate the effect of CPAP treatment on blood pressure (BP) in normotensive patients with dipper circadian pattern with sleep apnea-hypopnea syndrome (SAHS). The secondary objectives are: i) To evaluate the prevalence of the different circadian patterns of BP in ambulatory blood pressure monitoring (ABPM) ii) To establish the relationship between CPAP compliance and BP response; iii) Identify which ABPM variables and biomarkers are related to BP response; iv) Evaluate changes in the biomarkers' profile with the CPAP treatment. Methodology: Open-label, parallel, prospective, randomized and controlled trial including normotensive patients diagnosed with severe SAHS without significant somnolence. 64 patients with dipper circadian pattern will be included and will be randomized to receive CPAP (32) or conservative treatment (32). ABPM and blood sample collection will be performed at the beginning of the study and at 3 months.


  1. Recruitment: Normotensive subjects referred to the sleep unit of the Hospital Santa Maria (Spain) who are diagnosed of severe OSA (AHI≥30) by a sleep study and dipper circadian blood pattern confirmed by ABPM and who do not present significant somnolence (Epworth≤18) will be included in the study.
  2. Definition of the groups: Patients will be randomized to receive one of the following
    1. CPAP: Patients who will receive CPAP treatment. The CPAP titration will be carried out with an automatic or manual CPAP according to usual clinical practice.
    2. Conservative treatment: Patients who will receive conservative treatment based on hygienic-dietetic measures.
    3. Randomization: It will be carried out with an automated platform
    4. Duration of the treatment: All patients randomized to CPAP will begin treatment as soon as possible after randomization, and will continue treatment until the study ends (3 months).

Patients who interrupt treatment will be excluded from the study. ABPM and blood sample collection will be performed on all included patients at the beginning of the study and at 3 months under treatment (CPAP or conservative care).

5. Follow-up: All patients will be evaluated at the beginning of the study (T0), at first month (T1) and at three months (T2), during the follow-up period.

Condition Normotensive, Sleep Apnea, Obstructive
Treatment CPAP Treatment
Clinical Study IdentifierNCT03948373
SponsorSociedad Española de Neumología y Cirugía Torácica
Last Modified on13 May 2022


Yes No Not Sure

Inclusion Criteria

Men and women over 18 years of age
Referred to the sleep unit for suspected OSA
Being normotensive and presenting an AHI ≥ 30 in the sleep study
Signature of the informed consent

Exclusion Criteria

Previous CPAP treatment
Significant somnolence defined by an Epworth Sleepiness Scale (ESS) score higher than 18
Psychophysical inability to complete questionnaires
Previous diagnosis or suspicion of another sleep disorder
Presence of more than 50% of central apneas or Cheyne-Stokes respiration
Having a serious chronic disease: neoplasia, renal failure, severe chronic obstructive pulmonary disease, chronic depression and other chronic limiting diseases
Medical history that may interfere with the objectives of the study or, in the opinion of the researcher, may compromise the conclusions
Any medical, social or geographical factor that may endanger the patient's compliance 9-Having a profession of high risk (professional driver)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note